{'output': [['Portage Biotech Inc.', 'ORG', 'Announce', 'Trading Halt', 'EVENT'], ['Portage Biotech Inc.', 'ORG', 'Operate_In', 'Canadian Securities Exchange', 'ORG/GOV'], ['Canadian Securities Exchange', 'ORG/GOV', 'Issue', 'Bulletin 2018-0101', 'EVENT'], ['Portage Biotech Inc.', 'ORG', 'Work_With', 'Canadian Securities Exchange', 'ORG/GOV'], ['Portage Biotech Inc.', 'ORG', 'Work_With', 'IIROC', 'ORG/REG'], ['IIROC', 'ORG/REG', 'Issue', 'Trade Ruling', 'EVENT'], ['Portage Biotech Inc.', 'ORG', 'Have', 'Trading Halt Lifted', 'EVENT'], ['Portage Biotech Inc.', 'ORG', 'Reiterate', 'Record Date', 'EVENT'], ['Portage Biotech Inc.', 'ORG', 'Reiterate', 'Distribution Date', 'EVENT'], ['Portage', 'ORG', 'Engage_In', 'Discovery and Development', 'CONCEPT'], ['Portage', 'ORG', 'Seek', 'Sell or License', 'CONCEPT'], ['Portage', 'ORG', 'Have_Interest_In', 'Novel Targeted Therapies', 'CONCEPT'], ['Portage', 'ORG', 'Have_Interest_In', 'Stem Cell Therapies', 'CONCEPT'], ['Portage', 'ORG', 'Have_Interest_In', 'New Indications', 'CONCEPT'], ['Portage', 'ORG', 'Have_Interest_In', 'Older Marketed Products', 'CONCEPT'], ['Portage', 'ORG', 'Have_Interest_In', 'Novel Patentable Characteristics', 'CONCEPT'], ['Portage', 'ORG', 'Have_Interest_In', 'New Value to Patients', 'CONCEPT'], ['Biohaven Pharmaceutical Holding Company Ltd.', 'ORG', 'Be_Proposed_Stock_Dividend', 'EVENT'], ['Portage', 'ORG', 'Refer_To', 'Press Release', 'EVENT'], ['Portage', 'ORG', 'Make', 'Forward-Looking Statements', 'CONCEPT'], ['Company', 'ORG', 'Have', 'Management', 'PERSON'], ['Company', 'ORG', 'Not_Actually_Achieve', 'Plans and Objectives', 'CONCEPT'], ['Company', 'ORG', 'Have', 'Uncertainties', 'CONCEPT'], ['Company', 'ORG', 'Have', 'Risk Factors', 'CONCEPT']]}